2024 Was a Banner Year for FAPI Tech Transfer!

Thanks to the diligent efforts of our team, 18F-FAPI-74 production is now live at FIVE sites in SOFIE’s network – Totowa, NJ; Gilroy, CA; Romeoville, IL; Sanford, FL, and Cleveland, OH. Most of these activations took place in 2024 with additional sites planned for 2025. This growth in FAPI-74 manufacturing capability uniquely positions us to support our upcoming 18F-FAPI-74 clinical studies and academic investigator-initiated studies, in addition to companion use of 18F-FAPI-74 in Pharma collaborations.  Building the partnership between our clinical development pipeline and high-capacity radiopharmaceutical network is a major step forward!

Alyse Zeller, Director of CMC, remarked, “I am proud to support the distribution leap the FAPI Program has been able to take this past year and am looking forward to further expansion and collaborations in the coming years. I am extremely grateful to Frank Valla, Juliana Agudelo PhD, Julian Nwoko, Zachary Nulph, Nicolle Ferrel, Randy Marquez, Priyanka Patel, Laura Crandall-Carney PhD, and the RCM and Training Teams for their invaluable contributions, teamwork, and dedication that cannot be overstated in the success of these activations.”

If you are interested in partnering with SOFIE for access to 18F-FAPI-74, please contact fapiprogram@sofie.com .